Research Articles Issue 2 · 2018 · pp. 203–209 · Issue page

PAPILLARY THYROID CANCER- A CASE OF LOCO-REGIONAL AGGRESSIVNESS

TI
CA
MI
DI
CR
VL
LU
1 Department of Surgery, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, The CF Hospital of Craiova
2 Department of Endocrinology, CF Hospital of Craiova
3 Department of Metabolism and Nutrition Diseases, Faculty of Medicine, University of Medicine and Pharmacy of Craiova
4 Department of Metabolism and Nutrition Diseases, Municipal Clinical Hospital “Filantropia”
5 PhD student , Department of Pharmacology, University of Medicine and Pharmacy of Craiova
6 University of Medicine and Pharmacy of Craiova, Bucharest Universitary Emergency Hospital, Surgery Department
7 Department of Hygiene, Faculty of Medicine, University of Medicine and Pharmacy of Craiova
Corresponding author: [email protected]
Accepted 28 March 2026
Available Online 15 November 2018
ALTHOUGH THYROID CANCER IS RELATIVELY UNCOMMON COMPARED TO OTHER CANCERS, THYROID REPRESENTS THE MOST FREQUENTLY LOCATION FOR MALIGN TUMORS WHEN IT COMES TO ENDOCRINE SYSTEM. WHEN IT COMES TO STATISTICS, THYROID CANCER IS MORE FREQUENT IN WOMEN THAT IN MEN WITH A RATIO OF 3:1 AND IT CAN OCCU R AT ANY AGE BUT WITH A HIGHER INCIDENCE OVER 30 YEARS OLD AND ITS AGGRESSIVENESS INCREASES SIGNIFICANTLY IN OLDER PATIENTS.8 THE “GOLDEN STANDARD” FOR THE TREATMENT OF THYROID CANCER REMAINS THE SURGERY, ALTHOUGH, THYROIDECTOMY OFTEN IS NOT ENOUGH SO THE TREATMENT MAY BE COMPLETED WITH RADIOTHERAPY, RADIOACTIVE IODINE, CHEMOTHERAPY OR HORMONE THERAPY. OVERALL, THE PROGNOSIS FOR MOST PATIENTS DIAGNOSED WITH PAPILLARY OR FOLLICULAR THYROID CANCER IS USUALLY AN EXCELLENT ONE.
PAPILLARY THYROID CANCER TOTAL THYROIDECTOMY PARTIAL DYSPHAGIA
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.